The Histology And Cytology Market Is Estimated To Witness High Growth Owing To Increasing Incidence Of Cancer
Histology And Cytology Market
Market
Overview:
Histology involves the microscopic examination of tissue samples to study the
details of cellular structures. Cytology involves the examination of cell
samples from body fluids like urine, sputum, cerebrospinal fluid, etc. for
detection of cancer and other diseases. These techniques play a crucial role in
cancer diagnosis, staging, prognosis and management. The broad applications of
histology and cytology techniques are in diagnosing diseases like cancer,
infections and hematological disorders.
Market Dynamics:
The histology and cytology market is primarily driven by the increasing
incidence of cancer globally. According to World Health Organization (WHO),
cancer is a leading cause of death worldwide, accounting for nearly 10 million
deaths in 2020. The other key drivers include increasing investments in cancer
research, rising awareness about advanced diagnostic techniques and growing
demand for minimally invasive procedures. Moreover, technological advancements
leading to better tissue processing, staining methods and microscope imaging
are further fueling the market growth. However, high cost of advanced
instruments and lack of skilled professionals and standardized practices pose
challenges to market growth.
SWOT Analysis
Strength: Histology and cytology market has three technical strengths that
include high growth potential due to increasing prevalence of cancer worldwide,
advanced digital pathology solutions that improve efficiency and diagnostic
accuracy, and automated staining systems reduce manual tasks and turnaround
time.
Weakness: Histology and cytology market faces challenges in lack of pathologist
specializing in diagnostic techniques, high installation and maintenance cost
of digital pathology solutions limits adoption in low resource setting, and
technical limitations of automated staining systems.
Opportunity: Key growth opportunities lie in untapped emerging markets of Asia
Pacific and Latin America due to rising healthcare expenditure, and adoption of
companion diagnostics using cytology and histology samples offers synergies in
personalized medicine.
Threats: stringent regulatory guidelines for approval of new digital pathology
solutions, and threat from refurbished equipment and reagents limit pricing
flexibility of key players.
Key Takeaways
The Global
Histology And Cytology Market Demand is expected to witness high
growth, exhibiting CAGR of 13% over the forecast period, due to increasing
prevalence of cancer worldwide. The market size for 2023 is US$ 20,882.22 Mn.
Regional analysis: North America is expected to dominate the histology and
cytology market during the forecast period. Presence of major market players,
early adoption of advanced digital pathology solutions, and large cancer
patient pool are major factors contributing to its large market share. Asia
Pacific is poised to grow at a fastest pace due to growing healthcare infrastructure,
rising medical tourism, and increasing cancer incidence.
Key players analysis: Key players operating in the histology and cytology
market are Abbott, Hologic Inc., Becton, Dickinson and Company, Southwest
Precision Instruments, LLC, F. Hoffmann-La Roche Ltd, Sysmex Corporation,
Thermo Fisher Scientific Inc., Danaher, Life Technologies Corporation, Merck
KGaA, Koninklijke Philips N.V., Perkin Elmer, and Trivitron Healthcare.
Key players are focusing on new product launches, mergers, acquisitions and
geographical expansion to strengthen their market presence. For instance, in
2022, Abbott launched pan-cancer liquid biopsy test to detect multiple cancer
types from a simple blood draw.
Read
More:
https://www.marketwebjournal.com/histology-and-cytology-market-growth-demand-and-overview/
Comments
Post a Comment